| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.078 | 0.1 |